Turtle (submersible)
Turtle was the world's first submersible vessel with a documented record of use in combat. It was designed and built in 1775 by the American inventor David Bushnell as a means of attaching explosive charges to ships in a harbor. Turtle was used during the American Revolutionary War in an attempt to sink the British warship HMS Eagle.
Design and Construction
The Turtle was constructed primarily of wood, reinforced with iron bands. It was shaped like a large clam and was about 7.5 feet (2.3 meters) long, 6 feet (1.8 meters) tall, and 3 feet (0.91 meters) wide. The vessel was designed to be operated by a single person and was equipped with a hand-cranked propeller for movement and a foot-operated pump for vertical motion. The submersible also featured a ballast tank that could be flooded or emptied to control buoyancy.
Operation
The Turtle was intended to be used at night to avoid detection. The operator would navigate the submersible to the target ship, attach a timed explosive charge to the hull, and then retreat. The explosive device, known as a "torpedo" in Bushnell's time, was essentially a keg of gunpowder with a clockwork detonator.
First Mission
The Turtle's first mission took place in September 1776, when it attempted to attack the British flagship HMS Eagle, which was moored in New York Harbor. The operator, Sergeant Ezra Lee, managed to navigate the Turtle to the target but was unable to successfully attach the explosive charge due to the ship's copper sheathing. Despite this failure, the mission demonstrated the potential of submersible warfare.
Legacy
Although the Turtle was not successful in its mission, it represented a significant technological advancement in naval warfare. It laid the groundwork for future developments in submarine design and underwater combat. The principles and concepts pioneered by Bushnell in the Turtle influenced later inventors and engineers, including those who developed the CSS Hunley during the American Civil War.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD